Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine
NCT02968420
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Human Papillomavirus
Interventions
BIOLOGICAL:
Human Papillomavirus 9-valent Vaccine, Recombinant
Sponsor
University of British Columbia
Collaborators
[object Object]